Header Logo

Connection

Megan Lerner to Recombinant Proteins

This is a "connection" page, showing publications Megan Lerner has written about Recombinant Proteins.
Connection Strength

0.091
  1. Preclinical Animal Studies of Intravesical Recombinant Human Proteoglycan 4 as a Novel Potential Therapy for Diseases Resulting From Increased Bladder Permeability. Urology. 2018 Jun; 116:230.e1-230.e7.
    View in: PubMed
    Score: 0.034
  2. A rapid bioassay for platelet-derived growth factor beta-receptor tyrosine kinase function. Biotechnology (N Y). 1994 Oct; 12(10):1008-11.
    View in: PubMed
    Score: 0.027
  3. Antitumor activity of SS(dsFv)PE38 and SS1(dsFv)PE38, recombinant antimesothelin immunotoxins against human gynecologic cancers grown in organotypic culture in vitro. Clin Cancer Res. 2002 Nov; 8(11):3520-6.
    View in: PubMed
    Score: 0.012
  4. cDNA cloning, DNA binding, and evolution of mammalian transcription factor IIIA. Gene. 2002 Jan 09; 282(1-2):43-52.
    View in: PubMed
    Score: 0.011
  5. Snmp-1, a novel membrane protein of olfactory neurons of the silk moth Antheraea polyphemus with homology to the CD36 family of membrane proteins. J Biol Chem. 1997 Jun 06; 272(23):14792-9.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.